Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Gingele S, Jacobus TL, Konen FF, Hümmert MW, Sühs KW, Schwenkenbecher P, Ahlbrecht J, Möhn N, Müschen LH, Bönig L, Alvermann S, Schmidt RE, Stangel M, Jacobs R, Skripuletz T.
Gingele S, et al. Among authors: bonig l.
Cells. 2018 Dec 28;8(1):12. doi: 10.3390/cells8010012.
Cells. 2018.
PMID: 30597851
Free PMC article.